Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on September 2, 2025
Debra Gudema Recognized by Mothers Against Drunk Driving with Leadership Certificate
Debra Gudema Receives MADD Leadership Certificate BOCA RATON, FL, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Wellness writer and community advocate Debra Gudema has been honored by Mothers Against Drunk Driving (MADD) with a Leadership …
FROM THE HEART: HORIZON CARE SERVICES HONORS 21 YEARS OF SERVING SENIORS
NORTH PALM BEACH, FL, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Celebrating over two decades of compassionate service, Horizon Care Services continues to deliver exceptional in-home care for South Florida’s seniors—empowering independence, …
Senior Helpers Opens Doors in the Miami-Dade Area
New Senior Helpers Location opened in the Miami-Dade area. Offering services that reduce hospitalization and support seniors aging in place. MIAMI LAKES, FL, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Senior Helpers, the nation’s premier …
Careficient Welcomes Bristol Hospice to the Careficient EMR Platform
Transition from legacy EMR to Careficient reflects shared focus on innovation, operational efficiency, and compassionate care delivery. JENSEN BEACH, FL, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- Careficient, a leading provider of EMR …
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
TOKYO and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference
LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and …
Flex Raises $15M to Unlock $150B in Untapped Pre-Tax Spending for Leading Health & Wellness Retailers
SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Flex, the leading platform that enables health and wellness brands to accept Health Savings Account (HSA) and Flexible Spending Account (FSA) payments, has raised $15 million in Series A funding, bringing …
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Korro to Participate in Upcoming Investor and Scientific Conferences
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 …
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows: Morgan …
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs
Nyxoah Annonce ses Prochains Événements Destinés aux Investisseurs Mont-Saint-Guibert, Belgique – 2 septembre 2025, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to …
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President …
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …